309 related articles for article (PubMed ID: 34481011)
21. On employing a translationally controlled tumor protein-derived protein transduction domain analog for transmucosal delivery of drugs.
Bae HD; Lee K
J Control Release; 2013 Sep; 170(3):358-64. PubMed ID: 23791976
[TBL] [Abstract][Full Text] [Related]
22. Intranasal Lipid Particulate Drug Delivery Systems: An Update on Clinical Challenges and Biodistribution Studies of Cerebroactive Drugs in Alzheimer's disease.
Arora D; Bhatt S; Kumar M; Vattikonda HDC; Taneja Y; Jain V; Joshi V; Gali CC
Curr Pharm Des; 2020; 26(27):3281-3299. PubMed ID: 32228421
[TBL] [Abstract][Full Text] [Related]
23. Intranasal Drug Delivery: A Non-Invasive Approach for the Better Delivery of Neurotherapeutics.
Kumar H; Mishra G; Sharma AK; Gothwal A; Kesharwani P; Gupta U
Pharm Nanotechnol; 2017; 5(3):203-214. PubMed ID: 28521670
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms and solutions for nasal drug delivery - a narrative review.
Ulusoy S; Bayar Muluk N; Karpischenko S; Passali GC; Negm H; Passali D; Milkov M; Kopacheva-Barsova G; Konstantinidis I; Dilber M; Cingi C
Eur Rev Med Pharmacol Sci; 2022 Dec; 26(2 Suppl):72-81. PubMed ID: 36524914
[TBL] [Abstract][Full Text] [Related]
25. Nanomedicine for Intranasal Delivery to Improve Brain Uptake.
Patel AA; Patel RJ; Patel SR
Curr Drug Deliv; 2018; 15(4):461-469. PubMed ID: 29034836
[TBL] [Abstract][Full Text] [Related]
26. Intranasal drug delivery: opportunities and toxicologic challenges during drug development.
Keller LA; Merkel O; Popp A
Drug Deliv Transl Res; 2022 Apr; 12(4):735-757. PubMed ID: 33491126
[TBL] [Abstract][Full Text] [Related]
27. Drug Delivery and Targeting to the Brain Through Nasal Route: Mechanisms, Applications and Challenges.
Kashyap K; Shukla R
Curr Drug Deliv; 2019; 16(10):887-901. PubMed ID: 31660815
[TBL] [Abstract][Full Text] [Related]
28. Challenges in nasal drug absorption: how far have we come?
Agu RU
Ther Deliv; 2016 Jul; 7(7):495-510. PubMed ID: 27403632
[TBL] [Abstract][Full Text] [Related]
29. [Drug delivery system for diabetes].
Yamasaki Y
Nihon Rinsho; 1998 Mar; 56(3):748-51. PubMed ID: 9549368
[TBL] [Abstract][Full Text] [Related]
30. New strategies to improve the intranasal absorption of insulin.
Duan X; Mao S
Drug Discov Today; 2010 Jun; 15(11-12):416-27. PubMed ID: 20359545
[TBL] [Abstract][Full Text] [Related]
31. Smart polymers for controlled delivery of proteins and peptides: a review of patents.
Fogueri LR; Singh S
Recent Pat Drug Deliv Formul; 2009 Jan; 3(1):40-8. PubMed ID: 19149728
[TBL] [Abstract][Full Text] [Related]
32. Quantitative Estimation of the Effect of Nasal Mucociliary Function on in Vivo Absorption of Norfloxacin after Intranasal Administration to Rats.
Inoue D; Kimura S; Kiriyama A; Katsumi H; Yamamoto A; Ogawara KI; Higaki K; Tanaka A; Yutani R; Sakane T; Furubayashi T
Mol Pharm; 2018 Oct; 15(10):4462-4469. PubMed ID: 30165013
[TBL] [Abstract][Full Text] [Related]
33. Efficiency of cell-penetrating peptides on the nasal and intestinal absorption of therapeutic peptides and proteins.
Khafagy el-S; Morishita M; Kamei N; Eda Y; Ikeno Y; Takayama K
Int J Pharm; 2009 Oct; 381(1):49-55. PubMed ID: 19646515
[TBL] [Abstract][Full Text] [Related]
34. Permeability issues in nasal drug delivery.
Arora P; Sharma S; Garg S
Drug Discov Today; 2002 Sep; 7(18):967-75. PubMed ID: 12546871
[TBL] [Abstract][Full Text] [Related]
35. Nasal route for vaccine and drug delivery: Features and current opportunities.
Lobaina Mato Y
Int J Pharm; 2019 Dec; 572():118813. PubMed ID: 31678521
[TBL] [Abstract][Full Text] [Related]
36. Muco-adhesive multivesicular liposomes as an effective carrier for transmucosal insulin delivery.
Jain AK; Chalasani KB; Khar RK; Ahmed FJ; Diwan PV
J Drug Target; 2007 Jul; 15(6):417-27. PubMed ID: 17613660
[TBL] [Abstract][Full Text] [Related]
37. [
Bakhrushina EO; Mikhel JB; Kondratieva VM; Demina NB; Grebennikova TV
Vopr Virusol; 2022 Nov; 67(5):395-402. PubMed ID: 36515285
[TBL] [Abstract][Full Text] [Related]
38. Transdermal innovations in diabetes management.
Rao R; Mahant S; Chhabra L; Nanda S
Curr Diabetes Rev; 2014; 10(6):343-59. PubMed ID: 25418713
[TBL] [Abstract][Full Text] [Related]
39. Intranasal delivery of ciprofloxacin to rats: A topical approach using a thermoreversible in situ gel.
Sousa J; Alves G; Oliveira P; Fortuna A; Falcão A
Eur J Pharm Sci; 2017 Jan; 97():30-37. PubMed ID: 27810560
[TBL] [Abstract][Full Text] [Related]
40. In situ gel-forming system: an attractive alternative for nasal drug delivery.
Wang X; Liu G; Ma J; Guo S; Gao L; Jia Y; Li X; Zhang Q
Crit Rev Ther Drug Carrier Syst; 2013; 30(5):411-34. PubMed ID: 24099327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
